|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date27 Oct 2006 |
以安慰剂为对照,通过24小时吗啡平均累计用量,评价右酮洛芬氨丁三醇注射液用于术后镇痛的验证性临床研究
[Translation] A confirmatory clinical study on the use of dexketoprofen tromethamine injection for postoperative analgesia based on the average cumulative dose of morphine in 24 hours with placebo as control
以安慰剂为对照,评价右酮洛芬氨丁三醇注射液用于术后镇痛的有效性和安全性, 预期能减少24小时吗啡累计用量
[Translation] To evaluate the efficacy and safety of dexketoprofen tromethamine injection for postoperative analgesia with placebo as control, it is expected to reduce the cumulative 24-hour morphine consumption
[Translation] Pharmacokinetic study of dexketoprofen tromethamine injection in humans
考察健康志愿者单次静脉滴注及多次静脉滴注右酮洛芬氨丁三醇注射液后血药浓度经时变化过程及单次静脉滴注后尿药经时排泄情况,评价其在人体内的药代动力学特征,为临床研究提供参考依据
[Translation] To investigate the time course of blood drug concentration and urinary drug excretion after single intravenous infusion and multiple intravenous infusion of dexketoprofen tromethamine injection in healthy volunteers. Pharmacokinetic characteristics in human body to provide reference for clinical research
评价右酮洛芬氨丁三醇注射液治疗术后疼痛的多中心随机、盲法、安慰剂平行对照的安全性和有效性临床试验
[Translation] A multicenter randomized, blinded, placebo-controlled clinical trial evaluating the safety and efficacy of dexketoprofen tromethamine injection in the treatment of postoperative pain
评价右酮洛芬氨丁三醇注射液治疗术后疼痛的安全性和有效性
[Translation] To evaluate the safety and efficacy of dexketoprofen tromethamine injection in the treatment of postoperative pain
100 Clinical Results associated with Germany Berlin Chemical Co., Ltd. Beijing Office
0 Patents (Medical) associated with Germany Berlin Chemical Co., Ltd. Beijing Office
100 Deals associated with Germany Berlin Chemical Co., Ltd. Beijing Office
100 Translational Medicine associated with Germany Berlin Chemical Co., Ltd. Beijing Office